IDFX:LSE:LSE-iShares China Large Cap UCITS (USD)

ETF | Others |

Last Closing

USD 99.85

Change

+2.13 (+2.17)%

Market Cap

N/A

Volume

8.98K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+1.50 (+0.82%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-0.06 (-0.05%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.17 (+1.21%)

USD 572.76B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.20 (+1.11%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.35 (-0.50%)

USD 266.08B
0QZO:LSE 0QZO

+0.25 (+0.27%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.32 (+1.02%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

+1.69 (+1.01%)

USD 202.26B
0R24:LSE Intel Corp.

+0.22 (+0.99%)

USD 196.14B

ETFs Containing IDFX:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 45.05% 97% N/A 95% A
Dividend Return 2.76% 73% C 85% B
Total Return 47.81% 97% N/A 95% A
Trailing 12 Months  
Capital Gain 35.32% 89% A- 83% B
Dividend Return 2.58% 62% D 80% B-
Total Return 37.89% 90% A- 85% B
Trailing 5 Years  
Capital Gain -11.28% 18% F 32% F
Dividend Return 5.53% 58% F 70% C-
Total Return -5.75% 18% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain -9.68% N/A N/A 14% F
Dividend Return -8.72% N/A N/A 15% F
Total Return 0.96% N/A N/A 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 17.16% N/A N/A 58% F
Risk Adjusted Return -50.82% N/A N/A 15% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike